RECENT NEWS

Congress: what an exhibition of excellence

Congress: what an exhibition of excellence

While most people are still enjoying their summer holiday, planning for the IBMS Congress 2019 is already well underway, with the exhibition taking shape. The leading diagnostics companies have booked their exhibition space and are beginning their planning for product launches and demonstrations.
The impact of genomics on pathology

The impact of genomics on pathology

For many years, genomic techniques such as gene panel testing and fluorescence in situ hybridisation (FISH) have been used to guide treatment decisions for cancer patients. Large-scale molecular studies have also identified new disease classifiers and highlighted the potential to gain prognostic and predictive information to influence patient management. Also, ‘mutational signatures’ or patterns of alterations across the genome have been identified for different cancer types, and some of these are being evaluated for their power to predict drug response and patient prognosis. Today the potential of the genomics revolution to transform personalised medicine is a focus of healthcare systems across the world, and the UK is leading the way with the 100,000 Genomes Project, as Dr Clare Craig and Professor Louise Jones explain.
Rift Valley fever: new insight, and hope for the future

Rift Valley fever: new insight, and hope for the future

Health control measures alone could be ineffective in the long-term fight against Rift Valley fever, which affects both humans and animals, according to a new study published in Proceedings of the National Academy of Sciences of the United States of America.
Care, dedication and commitment recognised by Beckman award

Care, dedication and commitment recognised by Beckman award

A 28-year-old African community youth worker, Evah Namakula, has won the first global CARES HIV/AIDS award, designed to recognise ordinary people who have shown ‘care, dedication and commitment’ in their communities as part of the fight against the disease.
Evaluation of haematology POCT in oncology

Evaluation of haematology POCT in oncology

Horiba UK Medical has announced the publication of two studies evaluating the use of its Yumizen H500 haematology analyser for point-of-care testing (POCT) to enhance the care of oncology patients. With near-patient, full blood count results, patients undergoing chemotherapy can receive treatment without delay and greatly reduce their hospital/clinic exposure times.

Reliable and timely microbiology services

Eurofins Biomnis is a provider of pathology diagnostic testing and offers reliable and timely services delivered by dedicated and fully trained staff. The company’s microbial testing range includes panels for sexually transmitted diseases (Atopobium, Chlamydia, Gardnerella, Mycoplasma, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma urealyticum), bacterial and viral infectious diseases (HIV, hepatitis B and C viruses, human papillomavirus, CMV, EBV, parvovirus, , measles, influenza, pneumonia), specialised parasitology (toxocariasis, amoebiasis, ascariasis, filariasis) and emerging microbial diseases such as Zika and dengue fever. By ensuring that every test is performed to the highest standard every time, Eurofins Biomnis can help its customers make better informed healthcare decisions for patients. www.eurofins.co.uk/biomnis/our-services/medical-testing/microbiology/
Molecular and phenotypic detection technologies

Molecular and phenotypic detection technologies

Hospitals are increasingly encountering unpredictable resistance patterns clinically while being faced with the need to minimise broad-spectrum antibiotic use to prevent and reduce antimicrobial resistance. For patients with sepsis, time to effective and optimised therapy is critical. Accelerate Diagnostics has created breakthrough diagnostic solutions by developing technologies that address the needs of clinicians and the laboratory.
Infectious disease researcher named Strathclyde Alumnus of the Year

Infectious disease researcher named Strathclyde Alumnus of the Year

One of the world’s leading researchers on HIV and AIDS has been named the University of Strathclyde’s Alumnus of the Year. Professor Mario Stevenson (Chief of the Division of Infectious Diseases, University of Miami) has received the award from his alma mater in recognition of his achievements in researching disease, notably AIDS/HIV.
Funding awarded to support an enzymatic process for DNA synthesis

Funding awarded to support an enzymatic process for DNA synthesis

Evonetix, the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, has been awarded substantial funding to support the development of a novel enzymatic approach to DNA synthesis. Innovate UK, the UK’s innovation agency, will co-fund the £1.3 million project, which will be undertaken in collaboration with Durham University.
Western blot imaging aids research in major Spanish hospital

Western blot imaging aids research in major Spanish hospital

A Syngene multi-application imager is being utilised by scientists at a major hospital in Spain to accelerate Western blot analysis of proteins expressed by white blood cells post-vaccination. Researchers are using the system to analyse rapidly and accurately ECL-labelled chemiluminescent Western blots of cellular receptors and proteins expressed by neutrophils and leucocytes. This fundamental research is allowing the scientists to detect changes in protein expression post-vaccination and is providing information to make predictions about the efficacy of, and potential adverse events associated with, clinical vaccines.
Portable laboratory for pathogen detection

Portable laboratory for pathogen detection

An independent technology and product development company, TTP, and Cubed Laboratories, a developer of rapid, DNA-based molecular diagnostic devices and test kits, have announced the successful completion of a project to develop Cubed’s core product, the NESDEP portable laboratory for pathogen detection. This accurate, high-throughput and easy-to-use system has benefits in the food safety industry and potentially beyond.
Minimising uncertainty in laboratory medicine

Minimising uncertainty in laboratory medicine

The issue of measurement uncertainty and its assessment has been a continuing theme across the past six issues of Pathology in Practice, and coverage of this topic concluded in the June issue. The series of articles has proved to be of considerable value to all those facing assessment by the United Kingdom Accreditation Service (UKAS) against the standards that comprise ISO 15189:2012 Medical laboratories – Requirements for quality and competence. However, uncertainty in its various other forms frequently emerges in this publication. The June cover topic is pre-eclampsia testing, and the latest National Institute for Health and Care Excellence (NICE) guidance that aims to limit the uncertainty around the possible development of this form of gestational hypertension (pictured) in late pregnancy.
Methotrexate and the treatment of rheumatoid arthritis: an update

Methotrexate and the treatment of rheumatoid arthritis: an update

Since the approval of methotrexate (MTX) for the treatment of rheumatoid arthritis (RA) 30 years ago, there have been a number of new findings about this drug. As a result, the mode of action is increasingly better understood, new indications are identified and the relevant aspects of patient adherence are defined. In practice, this leads to continued therapy optimisation, especially with regard to the dose and route of administration, which was emphasised at the recent Medac Symposium.
Meeting, learning and discovering

Meeting, learning and discovering

In May over 1200 scientists, technicians, speakers and exhibitors descended on the East Midlands Conference Centre at the University of Nottingham for the fifth Scientific Laboratory Show and Conference. Organised by Scientific Laboratory Supplies (SLS), the day brought together delegates from across the community, offering opportunities to meet like-minded people, learn new things and discover the very best scientific technology and equipment for the laboratory.
Celebrate art in science with the Image of the Year Award

Celebrate art in science with the Image of the Year Award

The Olympus Image of the Year European Life Science Light Microscopy Award 2018 recognises the very best in life science imaging. Participants can win a CX23 microscope with EP50 WiFi camera and iPad, an OM-D E-M5 Mark II camera, or a PEN E-PL8 camera.
Savings through quick adoption of new diagnostic techniques

Savings through quick adoption of new diagnostic techniques

Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) reveals that the NHS could save over £6.9 billion in five years through the quick adoption of new diagnostic tests as they come to the market. In turn, these savings could help tackle the annual NHS shortfall, widely expected to reach £20 billion by 2022. Patients would benefit from three new tests, for heart attack, pre-eclampsia and inflammatory bowel disease, by reducing unnecessary procedures and medication while delivering significant NHS savings.
Going Overboard with Microbiology – Women and Children First

Going Overboard with Microbiology – Women and Children First

Following on from a very successful Annual Scientific Meeting held in May, later in the year (Friday 19 October) the British Society for Microbial Technology (BSMT) will hold its Autumn Symposium at the Merseyside Maritime Museum in Liverpool, entitled: Going Overboard with Microbiology – Women and Children First.
Putting it all together: the assessment of uncertainty of measurement

Putting it all together: the assessment of uncertainty of measurement

In the June issue of Pathology in Practice, the seventh article by Stephen MacDonald brings the series on individual aspects of the assessment of uncertainty of measurement to a close. It provides an example of how to set, assess and review measurement uncertainty in any situation in the laboratory.
Strong feelings about point-of-care testing: a personal view

Strong feelings about point-of-care testing: a personal view

For the right reasons and in the right settings, point-of-care testing (POCT) is a great use of technology and could really improve efficiency for the NHS and convenience for the population. The big caveat is that it needs to be done when it is clinically appropriate and not just because technology makes it possible.
Going overboard with microbiology: a BSMT update

Going overboard with microbiology: a BSMT update

The 33rd Annual Scientific Meeting of the British Society for Microbial Technology (BSMT), held recently at PHE, Colindale, proved to be yet another resounding success. The focus of the meeting was Rapid Diagnostics – Time is Relative. Later in the year (Friday 19 October 2018), the BSMT will hold its Autumn Symposium at the Merseyside Maritime Museum in Liverpool, the theme being Going Overboard with Microbiology – Women and Children First.

Upcoming Events

Update Course in Gynaecological Cytology

London Regional Cytology Training Centre, Level 6X, St Marks Building, Watford Road, Harrow HA1 3UJ
12-14 December 2018

Managing Cultural Differences in the Workplace

The Holiday Inn - Kensington Forum, 97 Cromwell Road, London SW7 4DN
21 January 2019

British Society for Haematology Paediatric Symposium

Royal College of Paediatrics and Child Health, 5-11 Theobalds Road, London WC1X 8SH
14 February 2019

Challenges in the clinical biochemistry laboratory and beyond

The Royal College of Pathologists
28 February 2019

British Society for Haematology 59th Annual Scientific Meeting

SEC Glasgow
1-3 April 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Dec 2018

Molecular diagnostics and LAMP technology

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.